Free Trial

Jump Financial LLC Buys Shares of 33,468 The Lovesac Company (NASDAQ:LOVE)

Jump Financial LLC bought a new position in shares of The Lovesac Company (NASDAQ:LOVE - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 33,468 shares of the company's stock, valued at approximately $855,000. Jump Financial LLC owned approximately 0.22% of Lovesac as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of LOVE. SG Americas Securities LLC acquired a new stake in Lovesac in the fourth quarter valued at about $116,000. Barclays PLC raised its position in shares of Lovesac by 15.2% during the third quarter. Barclays PLC now owns 6,210 shares of the company's stock worth $124,000 after acquiring an additional 818 shares during the last quarter. Graham Capital Management L.P. bought a new position in shares of Lovesac during the third quarter worth about $255,000. International Assets Investment Management LLC bought a new position in shares of Lovesac during the fourth quarter worth about $261,000. Finally, Great Valley Advisor Group Inc. bought a new stake in Lovesac in the fourth quarter worth approximately $281,000. 91.32% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on LOVE shares. Oppenheimer lowered their target price on Lovesac from $60.00 to $35.00 and set an "outperform" rating for the company in a report on Wednesday, May 1st. Canaccord Genuity Group decreased their price objective on Lovesac from $44.00 to $36.00 and set a "buy" rating for the company in a report on Friday, April 12th. Roth Mkm restated a "buy" rating and set a $34.00 price objective on shares of Lovesac in a report on Wednesday, April 10th. Finally, Maxim Group assumed coverage on Lovesac in a report on Wednesday, April 17th. They set a "buy" rating and a $36.00 price objective for the company.


Get Our Latest Stock Analysis on LOVE

Lovesac Trading Down 1.2 %

Shares of NASDAQ:LOVE traded down $0.33 during mid-day trading on Monday, hitting $27.23. 341,325 shares of the company traded hands, compared to its average volume of 297,421. The stock has a market cap of $421.79 million, a P/E ratio of 19.45, a P/E/G ratio of 0.67 and a beta of 2.78. The Lovesac Company has a 12-month low of $14.18 and a 12-month high of $29.81. The stock has a 50-day moving average price of $22.91 and a two-hundred day moving average price of $22.93.

Lovesac (NASDAQ:LOVE - Get Free Report) last announced its earnings results on Thursday, April 11th. The company reported $1.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.93 by ($0.06). Lovesac had a net margin of 3.39% and a return on equity of 12.19%. The company had revenue of $250.00 million for the quarter, compared to analysts' expectations of $265.35 million. During the same period in the previous year, the firm earned $1.74 EPS. The firm's quarterly revenue was up 4.8% on a year-over-year basis. As a group, analysts expect that The Lovesac Company will post 1.18 earnings per share for the current year.

Insider Buying and Selling at Lovesac

In related news, CEO Shawn David Nelson sold 6,000 shares of the business's stock in a transaction on Friday, March 15th. The stock was sold at an average price of $22.44, for a total transaction of $134,640.00. Following the sale, the chief executive officer now directly owns 179,970 shares in the company, valued at approximately $4,038,526.80. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Lovesac news, Director Andrew R. Heyer purchased 3,856 shares of the stock in a transaction on Tuesday, April 16th. The shares were purchased at an average price of $18.76 per share, with a total value of $72,338.56. Following the acquisition, the director now directly owns 3,856 shares in the company, valued at approximately $72,338.56. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Shawn David Nelson sold 6,000 shares of the firm's stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $22.44, for a total value of $134,640.00. Following the transaction, the chief executive officer now directly owns 179,970 shares in the company, valued at $4,038,526.80. The disclosure for this sale can be found here. Corporate insiders own 12.09% of the company's stock.

About Lovesac

(Free Report)

The Lovesac Company designs, manufactures, and sells furniture. It offers sactionals, such as seats and sides; sacs, including foam beanbag chairs; and other products comprising drink holders, footsac blankets, decorative pillows, fitted seat tables, and ottomans. The company markets its products primarily through www.lovesac.com website, as well as showrooms at top tier malls, lifestyle centers, mobile concierges, kiosks, and street locations in 41 states in the United States; and in store pop-up- shops and shop-in-shops, and barter inventory transactions.

Featured Articles

Institutional Ownership by Quarter for Lovesac (NASDAQ:LOVE)

→ How Biden has already won 2024 (From Porter & Company) (Ad)

Should you invest $1,000 in Lovesac right now?

Before you consider Lovesac, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lovesac wasn't on the list.

While Lovesac currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: